NUREG-1566, STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report): Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(StriderTol Bot change)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Adams
#REDIRECT [[STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)]]
| number = ML19080A196
| issue date = 03/28/2019
| title = STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)
| author name = Kock A
| author affiliation = NRC/NMSS
| addressee name =
| addressee affiliation =
| docket =
| license number =
| contact person = McMurtary Anthony MSST/MSLB, 415-2746
| case reference number = STC-19-019
| document type = All Agreement States Letter type:NUREG
| page count = 3
}}

Latest revision as of 04:08, 5 January 2025

Redirect to:

Retrieved from "https://kanterella.com/w/index.php?title=NUREG-1566,_STC-19-019,_NUREG-1566_Volume_13_Revision_2_Consolidated_Guidance_About_Materials_Licenses:_Program_-Specific_Guidance_About_Commercial_Radiopharmacy_Licenses_(Final_Report)&oldid=4934804"